Clinical trial
A Prospective, Multi-center, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis
NCT07668895 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- July 31, 2028
- Enrollment
- 126 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.